Categories
Connect with us on LinkedIn
Achieving Post-Market Success: Harnessing RWE for Accelerated Market Acceptance
Watch our on-demand webinar featuring CVS Healthspire™ Life Sciences Solutions
Evaluating “Bother” as a Component of Patient-Reported Outcomes in Clinical Studies
Patient-reported outcome (PRO) instruments refer to multiple scales and questionnaires designed to collect patients’ personal feedback on their...
New Industry Standard Research Report Sheds Light on eCOA/ePRO Market Dynamics
The latest report from Industry Standard Research (ISR) Sheds Light on eCOA/ePRO Market Dynamics. The Performance of Castor...
Revolutionizing Blood Pressure Monitoring: Insights from Aktiia and Castor’s Collaboration
How Aktiia brought their continuous BP device to market by integrating vast amounts of blood pressure data with...
The impact of an AI-enabled consent process
Exploring how early engagement with trial participants through an AI enabled chatbot can enhance both comprehension and satisfaction.
Under Pressure: How Aktiia Brought Their Continuous BP Device to Global Markets with high quality data
Watch this on-demand LinkedIn Live webinar with Castor CEO & founder, Derk Arts, featuring fellow data-driven pioneer, Jay...
5 Best Practices for Getting Started with ePRO
Electronic Patient Reported Outcomes (ePRO) can become a powerhouse for gathering high-quality data directly from patients. To help...
Can BYOD help us end an era of waste and burden in eCOA?
Bring Your Own Device (BYOD) represents the future of eCOA, and prioritizes flexibility & convenience for trial participants....
Spring updates & a highlight on ePRO in Oncology
Listen in as Derk gives an update on what is happening at Castor this March, as well as...
Measuring the true patient experience in Cancer Trials with eCOA / ePRO
Shedding light on the complexities and advancements in measuring PROs, drug tolerability, and quality of life in cancer...
ePRO and Cancer Research: Measuring the true patient experience
In this on-demand webinar, we delve into the nuances of measuring true QOL & PRO for oncology trials.
The impact of ePRO on the patient & site journeys
Watch the recording of our product webinar on the impact of electronic Patient Reported Outcomes (ePRO) from two...
The Place of COAs / PROs in the Future of Healthcare
Learn how integrating Patient-Reported Outcomes (PROs) into clinical trials can drive success in Value-Based Care (VBC).
From Paper to eCOA / ePRO: Bringing flexibility & efficiency to your clinical trials
In this on demand webinar discover if your protocol is a good candidate for eCOA / ePRO, and...
Accelerating AI Innovation in Pharma: Collaboration versus Competition
Should clinical trial companies collaborate to speed up innovation in AI, or is a healthy dose of competition...
How Optina Diagnostics uses Castor EDC in research of earlier disease detection
Learn how partnering with Castor helped Optina to save time and money, and to gain FDA clearance for...
Castor collaborates with Microsoft to bring Practical AI to clinical trials.
Today, Castor announces its collaboration with Microsoft to integrate Practical AI in clinical trials, reducing trial burdens for...
eConsent Readiness Guide in 24 Countries
eConsent regulations can vary widely across borders. Download this whitepaper to learn the regulatory stances of 24 countries...
Connect with us on LinkedIn
